stella
beta
Study to Evaluate the Efficacy of Ruxolitinib 1.5% Cream in Adult Subjects with Discoid Lupus Erythematosus — Stella
Recruiting
Back to Discoid Lupus Erythematosus trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(2 sites)
Canada
INNO-6051 Site 03, Fredericton, New Brunswick
Innovaderm Research Inc., Montreal, Quebec
View full record on ClinicalTrials.gov